title: Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients.
abstract: OBJECTIVE
  This study reports the percentage of breast cancer survivors receiving ongoing benzodiazepines and the circumstances surrounding their usage.
  
  
  METHODS
  The medical records of 1,000 consecutive breast cancer survivors who were no longer receiving adjuvant chemotherapy were reviewed.
  
  
  RESULTS
  Among those patients, 7.9% (95% confidence interval 6.2-9.6; higher than the 3% rate in the general population) were receiving benzodiazepines. Lorazepam was most commonly prescribed. Sixty-eight patients were cancer free at their last visit, and 51 had not been taking benzodiazepines prior to their cancer diagnosis. Anxiety was the single most frequent reason for initiating and continuing benzodiazepines.
  
  
  CONCLUSIONS
  Anxiety appears to be a common explanation for relatively high rates of benzodiazepine use in breast cancer survivors. This finding merits further study.
authors: Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
authors: Rakhee
authors: R
authors: Vaidya
authors: Richa
authors: R
authors: Sood
authors: Nina
authors: N
authors: Karlin
authors: Aminah
authors: A
authors: Jatoi
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001007:Anxiety / Q000188:drug therapy*; D001569:Benzodiazepines / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality* / Q000523:psychology; D005260:Female; D006801:Humans; D008499:Medical Records; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000401:mortality / Q000523:psychology; D015996:Survival Rate; D017741:Survivors; D016896:Treatment Outcome
chemical_list: D001569:Benzodiazepines